Company / SG&A Expense
CROSS COUNTRY HEALTHCARE INC SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$200.7M
FY2025
5-year range
$182.0M / $324.2M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has declined for 3 consecutive years, from $324M in FY2022 to $201M in FY2025.
Based on SEC 10-K filings.
$201M in FY2025 with a 5-year CAGR of +2.2%.
Improved from $300M to $201M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- CROSS COUNTRY HEALTHCARE INC's sg&a expense has declined for 3 consecutive years.
- 5-year CAGR of +2.2%, indicating consistent growth.
- In FY2025, sg&a expense decreased 14.0% year-over-year.
- Peak sg&a expense was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $200.7M | -14.0% |
| FY2024 | $233.4M | -22.3% |
| FY2023 | $300.3M | -7.4% |
| FY2022 | $324.2M | +78.2% |
| FY2021 | $182.0M | +1.0% |
| FY2020 | $180.2M | -3.8% |
| FY2019 | $187.4M | +4.2% |
| FY2018 | $179.8M | +11.5% |
| FY2017 | $161.3M | +14.4% |
| FY2016 | $141.0M | +32.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026